Protara Therapeutics
Develops investigational therapies for cancer, lymphatic malformations, and patients receiving parenteral support.
$3.82
After-hours close+0.01 (+0.26%)
At close$3.81(−4.51%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.36 | — | — |
| Aug 2026 | −$0.33 | −$0.36 | −10.5% |
| May 2026 | −$0.36 | −$0.31 | +13.9% |
| Mar 2026 | −$0.32 | −$0.37 | −15.6% |
| Nov 2025 | −$0.39 | −$0.31 | +20.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.36 | — | — | — | — | — |
| Aug 11, 2026 | −$0.33 | −$0.36 | −10.5% | — | $180.0K | — |
| May 13, 2026 | −$0.36 | −$0.31 | +13.9% | — | — | — |
| Mar 10, 2026 | −$0.32 | −$0.37 | −15.6% | — | — | — |
| Nov 10, 2025 | −$0.39 | −$0.31 | +20.5% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 5, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 2, 2024 | ||||||
| Mar 13, 2024 | ||||||
| Nov 3, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 8, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 5, 2022 | ||||||
| Mar 9, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Jul 31, 2020 | ||||||
| May 13, 2020 | ||||||
| Mar 20, 2020 | ||||||
| Oct 31, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 8, 2019 | ||||||
| Mar 13, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 9, 2018 | ||||||
| Mar 14, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 10, 2017 | ||||||
| Mar 16, 2017 | ||||||
| Nov 7, 2016 | ||||||
| Aug 8, 2016 | ||||||
| May 9, 2016 | ||||||
| Mar 14, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Aug 13, 2015 | ||||||